Inovio Pharmaceuticals Inc. Stock Advances 10.2%, Outperforms Peers

Dow Jones
08/11

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. surged 10.2% to $0.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,605.36 and Dow Jones Industrial Average falling 0.1% to 53,975.98.

The stock's rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed 75.3% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $261.81, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.08% to $27.05.

Trading volume totaled 3.3 million, compared to the 50-day average of 2.6 million.

Data source: Dow Jones Market Data, FactSet

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10